Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Mike Sung; Alona Zer; Preet Walia; Leila Khoja; Manjula Maganti; Catherine Labbe; Frances A. Shepherd; Penelope A. Bradbury; Geoffrey Liu; Natasha B. Leighl

doi:10.21037/jtd.2020.04.30

Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Mike Sung, Alona Zer, Preet Walia, Leila Khoja, Manjula Maganti, Catherine Labbe, Frances A. Shepherd, Penelope A. Bradbury, Geoffrey Liu, Natasha B. Leighl^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Original language	English
Pages (from-to)	2706-2712
Number of pages	7
Journal	Journal of Thoracic Disease
Volume	12
Issue number	5
DOIs	https://doi.org/10.21037/jtd.2020.04.30
State	Published - 1 May 2020
Externally published	Yes

Funding

Funders	Funder number
Princess Margaret Cancer Foundation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.21037/jtd.2020.04.30

Cite this

@article{321c6736007a425284de5ecb16f0bdf3,

title = "Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer",

author = "Mike Sung and Alona Zer and Preet Walia and Leila Khoja and Manjula Maganti and Catherine Labbe and Shepherd, {Frances A.} and Bradbury, {Penelope A.} and Geoffrey Liu and Leighl, {Natasha B.}",

note = "Funding Information: Abstract previously presented at the 2018 International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer (WCLC), Toronto, ON. September 23–26, 2018. Funding: This study was supported by the Princess Margaret Cancer Foundation (NBL: OSI Pharmaceuticals Foundation Chair).",

year = "2020",

month = may,

day = "1",

doi = "10.21037/jtd.2020.04.30",

language = "אנגלית",

volume = "12",

pages = "2706--2712",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",

publisher = "Pioneer Bioscience Publishing Company (PBPC)",

number = "5",

}

TY - JOUR

T1 - Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

AU - Sung, Mike

AU - Zer, Alona

AU - Walia, Preet

AU - Khoja, Leila

AU - Maganti, Manjula

AU - Labbe, Catherine

AU - Shepherd, Frances A.

AU - Bradbury, Penelope A.

AU - Liu, Geoffrey

AU - Leighl, Natasha B.

N1 - Funding Information: Abstract previously presented at the 2018 International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer (WCLC), Toronto, ON. September 23–26, 2018. Funding: This study was supported by the Princess Margaret Cancer Foundation (NBL: OSI Pharmaceuticals Foundation Chair).

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85086029656&partnerID=8YFLogxK

U2 - 10.21037/jtd.2020.04.30

DO - 10.21037/jtd.2020.04.30

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:85086029656

SN - 2072-1439

VL - 12

SP - 2706

EP - 2712

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

IS - 5

ER -

Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Funding

UN SDGs

Access to Document

Other files and links

Cite this